Lipoprotein(a) in atrial fibrillation.
Lip
G Y
GY
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000503:physiopathology*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D011446:Prospective Studies; D012307:Risk Factors; D019851:Thrombophilia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D013927:Thrombosis / Q000517:prevention & control; D016277:Ventricular Function, Left / Q000502:physiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D017270:Lipoprotein(a); C036309:fibrin fragment D